Skip to main content

VRTX Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Vertex Pharmaceuticals Incorporated News

bluebird bio (Finally) Nears Approval. What's Next?

The gene therapy pioneer may earn approval years after initially teasing investors. It may not be time to celebrate.

Best Buy, Tyson Make Goldman List of Margin of Safety Stocks

The stocks could thrive amid the current uncertainty in the equity market and the economy, Goldman says.

Cathie Wood Watch: Ark Buys a Sagging Healthcare Stock

Ark did more selling than buying on April 29, including sale of a South African financial services company's stock.

Cathie Wood Watch: This Firm Programs Cells, Using DNA as Code

Wood's Ark Investment Management bought a series of biotech stocks, as it has done repeatedly in recent sessions.

Vertex Has a Pain Pill That May Replace Opioids

Vertex is one step closer to getting its new pain pill approved, which could substitute for opioids that are highly addictive.

Breaking News

FTX Reportedly Close to Buying BlockFi

An acquisition could take several months to close, and the price could shift between now and Friday.

Morningstar's Five Coping Mechanisms for Bear Market

The S&P 500 is in a bear market, having lost 20% so far this year. So what’s an investor to do?

Economist Roubini: Why Stocks Poised for 50% Wipeout

The stock market is off to its worst start to a year since 1962, with the S&P 500 dropping 21% in the first half of 2022.

Who Is the Mystery Crypto Queen on the Run After an Alleged Scam?

The FBI is offering anyone who helps arrest OneCoin co-founder Dr. Ruja Ignatova $100,000.